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Alexander F Bautista1 and Ozan Akca1,2*Abstract
Hypercapnic acidosis has been regarded as a tolerated side effect of protective lung ventilation strategies. Various
in vivo and ex vivo animal studies have shown beneficial effects in acute lung injury setting, but some recent work
raised concerns about its anti-inflammatory properties. This mini-review article aims to expand the potential clinical
spectrum of hypercapnic acidosis in critically ill patients with lung injury. Despite the proven benefits of hypercapnic
acidosis, further safety studies including dose-effect, level-and-onset of anti-inflammatory effect, and safe applicability
period need to be performed in various models of lung injury in animals and humans to further elucidate its
protective role.
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Management of critically ill patients has been continu-
ously evolving. Technological advancement has improved
the immediacy and quality of monitoring. Basic and trans-
lational researches have changed the approach in medical
management from simplistic acid–base approach to much
more sophisticated real-time compartmental electrolyte
assessments to neurally-adjusted ventilator management.
Now, we can follow inhaled-exhaled oxygen and carbon
dioxide levels at our bedside patient monitors, and assess
blood gas partial pressures as our stat labs.
Hypercapnia with and without acidosis has been ob-
served in critically ill patients for many decades. This
observation was either regarded as not beneficial or even
harmful mostly due to its pH-related effects and compli-
cated responses in the central nervous system. Recent
studies have shown compelling evidence suggesting bene-
ficial effects of hypercapnic acidosis in various different
lung injury models in animals and human [1-3]. The ma-
jority of basic and clinical work focused on ventilatory
strategies with regards to the beneficial effects of moderate
hypercapnia. This article aims to discuss the beneficial
and potentially harmful effects of permissive hypercapnia
in the perspective of critically ill patients with lung injury.* Correspondence: ozan.akca@louisville.edu
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Carbon dioxide & cellular compartments
Carbon dioxide (CO2) is a by-product of cellular respir-
ation. It plays a major role in the acid–base balance es-
sential for intracellular and extracellular hemostasis. It
has moderate water solubility. The reaction of dissolved
CO2 and water will yield carbonic acid, with the enzyme
carbonic anhydrase reversibly catalyzing the dissociation
of carbonic acid:
H20þ CO2 H2CO3 Hþ þ HCO3− Hþ þ CO32−
ð1Þ
Carbon dioxide moves across the intracellular com-
partment via a concentration gradient. It is actively re-
moved through exhalation by the respiratory system.
Changes in partial pressure of CO2 will effect changes in
hydrogen ion concentration.
Clinically established levels of carbon dioxide
The normal carbon dioxide tension is considered to be
within the range of 35–45 mmHg. Hypercapnia is gener-
ally defined as carbon dioxide partial pressure of higher
than 45 mmHg. Mild hypercapnia is noted to having
CO2 partial pressure of up to 50 mmHg [4,5]. Jung et. al,
defined moderate hypercapnia as PaCO2 levels between the
range of 55 to 70 mmHg [3]. Levels higher than 75 mmHg
are generally regarded as severe hypercapnia [6,7]. When
considering these arbitrary levels of hypercapnia, it isntral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Bautista and Akca Medical Gas Research 2013, 3:23 Page 2 of 5
http://www.medicalgasresearch.com/content/3/1/23important to emphasize that severity leveling of hypercap-
nia alone without a corresponding pH value, which is also
affected by metabolic changes, may not represent the ex-
pected frame of clinical effects.
Since there is an overlap between the partial CO2
ranges presented in most of the clinical studies cited in
this article, we are alluding to mild-to-moderate hypercap-
nia for discussion purposes. Significance and contribution
of acidosis levels are not equal between the studies cited.
Therefore, we tried to provide the contribution of acidosis
for each listed study.
Respiratory effects of hypercapnia
The main physiologic effect of increased CO2 in patients
would result in a right-ward shift of the oxygen dissoci-
ation curve which, in effect, improves unloading of oxygen
at the tissue level. In a canine model, arterial hypercapnia
produced a gradual and significant increase in oxygen car-
rying capacity [8]. An increase in intracellular H+ led to
decrease in pulmonary vascular resistance [9] abolishing
hypoxic pulmonary vasoconstriction, reduction in intra-
pulmonary shunting and improvement of ventilation-
perfusion mismatch [10]. Hypercapnia also attenuates fluid
dynamics in pulmonary vasculature, which would keep the
diffusion distance between the pulmonary capillary and
the alveoli short, thereby preserving optimal gas exchange
and preventing edema formation [11]. Although hypercap-
nia may notably increase pulmonary vascular resistance,
due to its overall effects in decreasing pro-inflammatory
response and fluid dynamics in the pulmonary vasculature,
the overall effect may not always appear as increased pul-
monary vascular resistance.
Effects on hemodynamics and oxygenation
Hypercapnia increases cardiac output, oxygen carrying
capacity, mixed venous oxygen, and also peripheral tis-
sue oxygenation [12-15]. The increases in cerebral tissue
oxygenation can be observed to some extent even when
cardiac output was kept constant [16] which can pos-
sibly be explained by the relationship of oxygen supply
and demand. Increase in cardiac output appears to be
related to inotropic effect through ß-adrenergic receptors,
and hypercapnia-induced sympathetic activation and cate-
cholamines [17,18]. Hypercapnia decreases systemic vas-
cular resistance, [19] which may further support tissue
perfusion especially when intravascular volume status is
maintained.
Cardiac index increases by about 10-15% for each 10-
mmHg increments in arterial carbon dioxide tension
within a range of 30 to 50 mmHg [12,20]. Additionally,
the rightward shift of the oxyhemoglobin dissociation
curve and decreases in systemic vascular resistance in-
crease oxygen availability to the peripheral tissue [20].
Ratnaraj et al. showed that increasing end-tidal carbondioxide tension from 30 to 50 mmHg improved both sub-
cutaneous tissue oxygen tension by ~ 23%, and intramural
oxygenation in large and small intestine by 16-to-45%
under general anesthesia in a pig model [21]. Fleischmann
et al. showed that even under high inspired oxygen con-
centration of 0.80 in colorectal surgery patients who were
assigned to mild hypercapnia (ET PCO2 of 50 mmHg),
subcutaneous tissue oxygenation increased by 38% and
colon intramural oxygenation increased by about 100%
compared to the patients who were assigned to normo-
capnia (ET PCO2 of 35 mmHg) [4]. More recently,
Schwartges et al. elegantly showed that incremental levels
of carbon dioxide increased cardiac output and systemic
oxygen delivery in dogs, which was measured as dissolved
oxygen and gastric mucosal oxygen saturation [22].
In spite of the positive oxygenation and perfusion effects
by hypercapnia as described above, it should also be noted
that myocardial depression due to overwhelming effects
on inotropy and catecholamines may develop at CO2 con-
centrations greater than 10-15% (i.e., PaCO2 > 75 mmHg)
[23,24] regardless of compensatory mechanisms to cor-
rect acidosis.
Hypercapnia & ventilator-associated lung injury (VALI)
Mechanical stress associated with overstretching alveoli
can cause lung injury. This is clearly evident with the
use of higher tidal volumes and increased transpulmon-
ary pressure during mechanical ventilation resulting in
ventilator associated lung injury (VALI). Experimental
studies have shown that lung injury markers such as the
presence of pulmonary edema, hyaline membranes, epithe-
lial injury, filtration coefficient [25] and lymphatic flow are
increased with higher tidal volumes [26]. To minimize this
insult, it has been advocated to utilize smaller tidal vol-
umes i.e. 7 ml/kg or less [27] and to limit the plateau air-
way pressure to 35 cm H2O or lower [28]. This in effect
will cause a slow increase in PaCO2 hence implementation
of permissive hypercapnia if there is no adjustment in re-
spiratory rate [2]. In a prospective randomized animal
study with moderate to severe ventilation-induced lung in-
jury, hypercapnic acidosis significantly reduced stretch-
induced lung injury and resulted in higher arterial PO2
compared to normocapnia. Moreover, it also showed re-
duction in lung permeability as evidenced by bronchoalve-
olar protein concentrations and attenuated the decrease in
static lung compliance in comparison with the normocap-
nia group [29]. This study confirms the growing body of
evidence that suggests hypercapnic acidosis involvement in
the inhibition of nuclear factor kappa-B (NF-KB) that regu-
lates genes central to lung injury, inflammation and repair.
In a large, randomized-controlled trial from the ARDS
Network, Kregenow and colleagues demonstrated that
permissive hypercapnia (pH < 7.35 and PCO2 > 45 mmHg)
reduced 28-day mortality in patients with acute lung injury
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weight tidal volume [30]. This is in part due the ability
of hypercapnic acidosis to attenuate physiologic and
histological indices of lung injury induced by very high
levels of lung stretch, [31] but not that due to the col-
lapse and re-expansion of atelectatic lung [1]. Laffey
and Kavanagh also stated that the combination of re-
duction of lung stretch and permissive hypercapnia is
additive in preventing VALI [32].
Hypercapnia & ventilator-induced diaphragmatic injury (VIDD)
Ventilator-induced diaphragmatic dysfunction (VIDD) is
another complication of prolonged controlled ventila-
tion. It may progress to diaphragmatic muscle atrophy
and result in long-term dependence on mechanical ven-
tilation [33]. Diaphragmatic muscle weakening can be
explained by proteolysis, apoptosis and oxidative stress,
[34] and it appears to be directly proportional to dur-
ation of mechanical ventilation; [35] anti-oxidant and
anti-inflammatory agents such as steroids may attenuate
the process [36,37].
Recently, Jung et al. reported that after 72 hours of
controlled mechanical ventilation, diaphragm contractions
to maximal stimulus were preserved in hypercapnic ani-
mals compared to a 25% decrease in the normocapnic
ventilated animals [38]. Controlling lung injury, prevent-
ing diaphragmatic dysfunction, and altering exaggerated
pro-inflammatory responses may suggest an important
potential role for mild-to-moderate hypercapnia and hy-
percapnic acidosis in acutely developing systemic inflam-
matory processes [39].
Hypercapnia in acute lung injury (ALI) and acute respiratory
distress syndrome (ARDS)
The causes of ALI and ARDS are varied, however, the
mainstay in the management of both disease processes
is mechanical ventilation, which can by itself further
result in VALI as described above. Hence, protective
ventilator strategy with permissive hypercapnia has been
studied both in human and animal models. Ischemia-
reperfusion injury is highly associated with the develop-
ment of ALI. Shibata et al. reported that hypercapnic
acidosis inhibits xanthine oxidase, and therefore pre-
vents an increase in capillary permeability, attenuates
free-radical-induced lung injury, and possibly prevents
apoptosis [40]. Other mechanisms by which hypercapnic
acidosis provide protection include attenuation of key
etiologic factors that lead to ALI, reduction of physical
lung damage, inhibition of key aspects of the inflamma-
tory response and direct protection of systemic organs
[41]. As mentioned above, the data published by the
ARDS Network and others have shown that hypercapnic
acidosis in this subset of patients had a reduced mortal-
ity [27,28,30].Hypercapnia, pneumonia & sepsis
Pneumonia and sepsis are the leading causes of increased
morbidity in critically ill patients [42]. Hypercapnic acid-
osis has shown to depress immune function through vari-
ous mechanisms via macrophage suppression, inhibition
of phagocytic function of neutrophils and cytokine signal-
ing [43,44]. However, most of these data reported in ani-
mal studies and in vitro models. Curley et al. stated that
hypercapnic acidosis inhibits the activation of NF-KB, [29]
which is responsible for activation and regulation of pro-
inflammatory and repair processes suggesting the reduc-
tion of pulmonary epithelial wound healing [45].
Such poor healing phenomenon was demonstrated in
in vitro studies using human bronchial epithelial cells
exposed to hypercapnia at neutral pH environment [46].
Despite this mechanistic effect of hypercapnia on the
immune system, hypercapnic acidosis has been shown to
improve physiologic indices of injury in the setting of
acute bacterial pneumonia [47]. Ni Chonghaile et. al.
demonstrated that hypercapnic acidosis attenuated the
increase in airway pressure and the decrease in both
lung compliance and arterial oxygenation in their animal
model via a neutrophil-independent mechanism [47]. In
a follow-up study, using their established pneumonia
model, they showed that the protective effects of hyper-
capnic acidosis are further enhanced with the use of ap-
propriate antibiotic therapy [48]. On the contrary, in
prolonged untreated pneumonia animal model, hyper-
capnic acidosis appeared to worsen lung indices in terms
of static compliance and arterial oxygenation, [49] and
was associated with higher bacterial count and increased
mortality [50].
With regard to systemic sepsis, animal models with
hypercapnic acidosis demonstrated improvement in he-
modynamic parameters, preserved central venous oxy-
gen saturation, slowed the development of hypotension,
and attenuated the associated increase in lactic acid con-
centration when compared to normocapnia [51-53]. Add-
itionally, hypercapnia may have some minimal effect in
preventing other infection such as surgical site infections
[54]. The clinical implication of hypercapnia in effect is also
dependent on the stage of the infection, i.e. early or late in
the course of the disease process; and also the primary site
of infection, may it be pulmonary or systemic source.
Summary
In conclusion, moderate hypercapnia may play a protect-
ive role and may be an integral part of ventilatory man-
agement of critically ill patients with VALI, VIDD, ALI
and ARDS. Regarding its role in immunomodulation, it
may be protective in the setting of acute pneumonia and
sepsis, provided adequate antibiotic coverage has been
instituted in a timely fashion. However, it should be
noted that moderate hypercapnia may worsen the injury
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ther clinical trials in animals, healthy human subjects,
and patients are needed to further assess the safety of
hypercapnia, to find the optimum dosing and timing,
and finally to elucidate its overall protective role.
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